Debt, Equity Markets Heat Up As Pharma M&A Soars
With pharmaceutical companies continuously peppering the market with multibillion-dollar deals, the hunt for attractive acquisition financing has lifted corporate debt offerings, equity offerings and even commitments from third-party lenders to new...To view the full article, register now.
Already a subscriber? Click here to view full article